nodes	percent_of_prediction	percent_of_DWPC	metapath
Allopurinol—XDH—Carboplatin—esophageal cancer	0.267	0.33	CbGbCtD
Allopurinol—XDH—Cisplatin—esophageal cancer	0.228	0.282	CbGbCtD
Allopurinol—AOX1—Methotrexate—esophageal cancer	0.171	0.212	CbGbCtD
Allopurinol—SLC22A7—Methotrexate—esophageal cancer	0.0889	0.11	CbGbCtD
Allopurinol—SLC22A8—Methotrexate—esophageal cancer	0.0543	0.0671	CbGbCtD
Allopurinol—AOX1—Nicotine Metabolism—CYP2A6—esophageal cancer	0.00597	0.109	CbGpPWpGaD
Allopurinol—AOX1—Tryptophan metabolism—ALDH3A2—esophageal cancer	0.00412	0.0757	CbGpPWpGaD
Allopurinol—AOX1—Effects of Nitric Oxide—NOS2—esophageal cancer	0.00234	0.043	CbGpPWpGaD
Allopurinol—XDH—Effects of Nitric Oxide—NOS2—esophageal cancer	0.00218	0.0399	CbGpPWpGaD
Allopurinol—SLC22A7—Fluoropyrimidine Activity—XRCC3—esophageal cancer	0.00201	0.0369	CbGpPWpGaD
Allopurinol—AOX1—Effects of Nitric Oxide—NOS3—esophageal cancer	0.00188	0.0345	CbGpPWpGaD
Allopurinol—XDH—Oxidative Stress—NFE2L2—esophageal cancer	0.00178	0.0327	CbGpPWpGaD
Allopurinol—XDH—Effects of Nitric Oxide—NOS3—esophageal cancer	0.00175	0.0321	CbGpPWpGaD
Allopurinol—SLC22A7—Fluoropyrimidine Activity—TYMP—esophageal cancer	0.00169	0.031	CbGpPWpGaD
Allopurinol—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—SLC52A3—esophageal cancer	0.00167	0.0307	CbGpPWpGaD
Allopurinol—XDH—Selenium Micronutrient Network—PRDX2—esophageal cancer	0.00131	0.024	CbGpPWpGaD
Allopurinol—XDH—Selenium Micronutrient Network—PRDX1—esophageal cancer	0.00131	0.024	CbGpPWpGaD
Allopurinol—AOX1—Tryptophan metabolism—ALDH2—esophageal cancer	0.00124	0.0228	CbGpPWpGaD
Allopurinol—SLC22A7—Fluoropyrimidine Activity—CYP2A6—esophageal cancer	0.00117	0.0215	CbGpPWpGaD
Allopurinol—XDH—Oxidative Stress—HMOX1—esophageal cancer	0.00106	0.0194	CbGpPWpGaD
Allopurinol—XDH—Nucleotide metabolism—TYMP—esophageal cancer	0.00103	0.0189	CbGpPWpGaD
Allopurinol—XDH—Oxidative Stress—SOD2—esophageal cancer	0.00099	0.0182	CbGpPWpGaD
Allopurinol—SLC22A7—Fluoropyrimidine Activity—SMUG1—esophageal cancer	0.000953	0.0175	CbGpPWpGaD
Allopurinol—AOX1—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000943	0.0173	CbGpPWpGaD
Allopurinol—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—GSTO1—esophageal cancer	0.000917	0.0168	CbGpPWpGaD
Allopurinol—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.000891	0.0163	CbGpPWpGaD
Allopurinol—AOX1—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000887	0.0163	CbGpPWpGaD
Allopurinol—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.000815	0.015	CbGpPWpGaD
Allopurinol—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.000749	0.0137	CbGpPWpGaD
Allopurinol—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.000685	0.0126	CbGpPWpGaD
Allopurinol—XDH—Selenium Micronutrient Network—PTGS1—esophageal cancer	0.000614	0.0113	CbGpPWpGaD
Allopurinol—Oliguria—Methotrexate—esophageal cancer	0.000459	0.00336	CcSEcCtD
Allopurinol—Hepatic failure—Capecitabine—esophageal cancer	0.000459	0.00336	CcSEcCtD
Allopurinol—Haemolytic anaemia—Capecitabine—esophageal cancer	0.000457	0.00334	CcSEcCtD
Allopurinol—Ulcer—Methotrexate—esophageal cancer	0.000447	0.00327	CcSEcCtD
Allopurinol—Renal failure acute—Capecitabine—esophageal cancer	0.000447	0.00327	CcSEcCtD
Allopurinol—Amnesia—Capecitabine—esophageal cancer	0.000439	0.00321	CcSEcCtD
Allopurinol—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.000437	0.0032	CcSEcCtD
Allopurinol—Renal impairment—Capecitabine—esophageal cancer	0.000433	0.00317	CcSEcCtD
Allopurinol—Vasculitis—Methotrexate—esophageal cancer	0.000433	0.00317	CcSEcCtD
Allopurinol—Dermatitis bullous—Capecitabine—esophageal cancer	0.000432	0.00316	CcSEcCtD
Allopurinol—Respiratory failure—Methotrexate—esophageal cancer	0.000431	0.00315	CcSEcCtD
Allopurinol—Purpura—Capecitabine—esophageal cancer	0.000428	0.00313	CcSEcCtD
Allopurinol—Pulmonary embolism—Methotrexate—esophageal cancer	0.000423	0.00309	CcSEcCtD
Allopurinol—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000423	0.00309	CcSEcCtD
Allopurinol—Cardiac failure—Capecitabine—esophageal cancer	0.000423	0.00309	CcSEcCtD
Allopurinol—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000421	0.00308	CcSEcCtD
Allopurinol—Stomatitis—Cisplatin—esophageal cancer	0.00042	0.00307	CcSEcCtD
Allopurinol—Conjunctivitis—Cisplatin—esophageal cancer	0.000419	0.00307	CcSEcCtD
Allopurinol—XDH—Selenium Micronutrient Network—SOD2—esophageal cancer	0.000419	0.00768	CbGpPWpGaD
Allopurinol—Hyponatraemia—Capecitabine—esophageal cancer	0.000414	0.00303	CcSEcCtD
Allopurinol—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000412	0.00302	CcSEcCtD
Allopurinol—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000408	0.00298	CcSEcCtD
Allopurinol—SLC22A7—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000405	0.00743	CbGpPWpGaD
Allopurinol—Skin exfoliation—Methotrexate—esophageal cancer	0.000404	0.00295	CcSEcCtD
Allopurinol—Face oedema—Capecitabine—esophageal cancer	0.000398	0.00291	CcSEcCtD
Allopurinol—Aplastic anaemia—Methotrexate—esophageal cancer	0.000397	0.0029	CcSEcCtD
Allopurinol—Bradycardia—Cisplatin—esophageal cancer	0.000394	0.00288	CcSEcCtD
Allopurinol—Ataxia—Capecitabine—esophageal cancer	0.000388	0.00284	CcSEcCtD
Allopurinol—Coma—Methotrexate—esophageal cancer	0.000387	0.00283	CcSEcCtD
Allopurinol—Blood creatinine increased—Capecitabine—esophageal cancer	0.000386	0.00283	CcSEcCtD
Allopurinol—Ecchymosis—Methotrexate—esophageal cancer	0.000382	0.0028	CcSEcCtD
Allopurinol—Urinary tract disorder—Cisplatin—esophageal cancer	0.000382	0.0028	CcSEcCtD
Allopurinol—Urethral disorder—Cisplatin—esophageal cancer	0.000379	0.00278	CcSEcCtD
Allopurinol—Gynaecomastia—Methotrexate—esophageal cancer	0.000378	0.00277	CcSEcCtD
Allopurinol—Abdominal pain upper—Capecitabine—esophageal cancer	0.000377	0.00276	CcSEcCtD
Allopurinol—Hypokalaemia—Capecitabine—esophageal cancer	0.000375	0.00275	CcSEcCtD
Allopurinol—Visual impairment—Cisplatin—esophageal cancer	0.000373	0.00273	CcSEcCtD
Allopurinol—Breast disorder—Capecitabine—esophageal cancer	0.000373	0.00273	CcSEcCtD
Allopurinol—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000371	0.00272	CcSEcCtD
Allopurinol—SLC22A7—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.00037	0.00679	CbGpPWpGaD
Allopurinol—Sepsis—Methotrexate—esophageal cancer	0.000367	0.00268	CcSEcCtD
Allopurinol—Gastritis—Capecitabine—esophageal cancer	0.000365	0.00267	CcSEcCtD
Allopurinol—Eye disorder—Cisplatin—esophageal cancer	0.000362	0.00265	CcSEcCtD
Allopurinol—Tinnitus—Cisplatin—esophageal cancer	0.000361	0.00264	CcSEcCtD
Allopurinol—Lymphadenopathy—Methotrexate—esophageal cancer	0.00036	0.00263	CcSEcCtD
Allopurinol—Flushing—Cisplatin—esophageal cancer	0.000359	0.00263	CcSEcCtD
Allopurinol—Cardiac disorder—Cisplatin—esophageal cancer	0.000359	0.00263	CcSEcCtD
Allopurinol—Abdominal distension—Capecitabine—esophageal cancer	0.000359	0.00263	CcSEcCtD
Allopurinol—Asthma—Capecitabine—esophageal cancer	0.000357	0.00261	CcSEcCtD
Allopurinol—Thrombophlebitis—Methotrexate—esophageal cancer	0.000355	0.00259	CcSEcCtD
Allopurinol—Diabetes mellitus—Methotrexate—esophageal cancer	0.000353	0.00258	CcSEcCtD
Allopurinol—Bronchospasm—Capecitabine—esophageal cancer	0.000351	0.00256	CcSEcCtD
Allopurinol—Immune system disorder—Cisplatin—esophageal cancer	0.00035	0.00256	CcSEcCtD
Allopurinol—Angina pectoris—Capecitabine—esophageal cancer	0.000347	0.00254	CcSEcCtD
Allopurinol—Sweating increased—Capecitabine—esophageal cancer	0.000347	0.00254	CcSEcCtD
Allopurinol—Alopecia—Cisplatin—esophageal cancer	0.000342	0.0025	CcSEcCtD
Allopurinol—Hepatic failure—Methotrexate—esophageal cancer	0.000342	0.0025	CcSEcCtD
Allopurinol—SLC22A8—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.00034	0.00624	CbGpPWpGaD
Allopurinol—Pancytopenia—Capecitabine—esophageal cancer	0.000339	0.00248	CcSEcCtD
Allopurinol—Malnutrition—Cisplatin—esophageal cancer	0.000337	0.00246	CcSEcCtD
Allopurinol—Dysuria—Capecitabine—esophageal cancer	0.000333	0.00244	CcSEcCtD
Allopurinol—Neutropenia—Capecitabine—esophageal cancer	0.000333	0.00244	CcSEcCtD
Allopurinol—Renal failure acute—Methotrexate—esophageal cancer	0.000333	0.00243	CcSEcCtD
Allopurinol—Flatulence—Cisplatin—esophageal cancer	0.000332	0.00243	CcSEcCtD
Allopurinol—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000325	0.00238	CcSEcCtD
Allopurinol—Weight increased—Capecitabine—esophageal cancer	0.000324	0.00237	CcSEcCtD
Allopurinol—Hyperglycaemia—Capecitabine—esophageal cancer	0.000322	0.00235	CcSEcCtD
Allopurinol—Depression—Capecitabine—esophageal cancer	0.000317	0.00232	CcSEcCtD
Allopurinol—Tremor—Cisplatin—esophageal cancer	0.000316	0.00231	CcSEcCtD
Allopurinol—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000315	0.00231	CcSEcCtD
Allopurinol—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000313	0.00229	CcSEcCtD
Allopurinol—Ill-defined disorder—Cisplatin—esophageal cancer	0.000313	0.00229	CcSEcCtD
Allopurinol—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000312	0.00228	CcSEcCtD
Allopurinol—Anaemia—Cisplatin—esophageal cancer	0.000311	0.00228	CcSEcCtD
Allopurinol—SLC22A8—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000311	0.00571	CbGpPWpGaD
Allopurinol—Jaundice—Capecitabine—esophageal cancer	0.00031	0.00227	CcSEcCtD
Allopurinol—Stomatitis—Capecitabine—esophageal cancer	0.00031	0.00227	CcSEcCtD
Allopurinol—Urinary tract infection—Capecitabine—esophageal cancer	0.000309	0.00226	CcSEcCtD
Allopurinol—Conjunctivitis—Capecitabine—esophageal cancer	0.000309	0.00226	CcSEcCtD
Allopurinol—Malaise—Cisplatin—esophageal cancer	0.000304	0.00222	CcSEcCtD
Allopurinol—Haematuria—Capecitabine—esophageal cancer	0.000303	0.00222	CcSEcCtD
Allopurinol—Leukopenia—Cisplatin—esophageal cancer	0.000302	0.00221	CcSEcCtD
Allopurinol—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000301	0.0022	CcSEcCtD
Allopurinol—Epistaxis—Capecitabine—esophageal cancer	0.0003	0.00219	CcSEcCtD
Allopurinol—Agranulocytosis—Capecitabine—esophageal cancer	0.000297	0.00217	CcSEcCtD
Allopurinol—Convulsion—Cisplatin—esophageal cancer	0.000292	0.00214	CcSEcCtD
Allopurinol—Bradycardia—Capecitabine—esophageal cancer	0.000291	0.00212	CcSEcCtD
Allopurinol—Ataxia—Methotrexate—esophageal cancer	0.000289	0.00211	CcSEcCtD
Allopurinol—Myalgia—Cisplatin—esophageal cancer	0.000287	0.0021	CcSEcCtD
Allopurinol—Haemoglobin—Capecitabine—esophageal cancer	0.000287	0.0021	CcSEcCtD
Allopurinol—Rhinitis—Capecitabine—esophageal cancer	0.000286	0.00209	CcSEcCtD
Allopurinol—Hepatitis—Capecitabine—esophageal cancer	0.000285	0.00209	CcSEcCtD
Allopurinol—Haemorrhage—Capecitabine—esophageal cancer	0.000285	0.00209	CcSEcCtD
Allopurinol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000285	0.00208	CcSEcCtD
Allopurinol—Hypoaesthesia—Capecitabine—esophageal cancer	0.000284	0.00208	CcSEcCtD
Allopurinol—Discomfort—Cisplatin—esophageal cancer	0.000283	0.00207	CcSEcCtD
Allopurinol—Pharyngitis—Capecitabine—esophageal cancer	0.000283	0.00207	CcSEcCtD
Allopurinol—Urinary tract disorder—Capecitabine—esophageal cancer	0.000282	0.00206	CcSEcCtD
Allopurinol—Urethral disorder—Capecitabine—esophageal cancer	0.00028	0.00205	CcSEcCtD
Allopurinol—Breast disorder—Methotrexate—esophageal cancer	0.000277	0.00203	CcSEcCtD
Allopurinol—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000277	0.00202	CcSEcCtD
Allopurinol—Oedema—Cisplatin—esophageal cancer	0.000275	0.00201	CcSEcCtD
Allopurinol—Anaphylactic shock—Cisplatin—esophageal cancer	0.000275	0.00201	CcSEcCtD
Allopurinol—Visual impairment—Capecitabine—esophageal cancer	0.000275	0.00201	CcSEcCtD
Allopurinol—Infection—Cisplatin—esophageal cancer	0.000273	0.002	CcSEcCtD
Allopurinol—Erythema multiforme—Capecitabine—esophageal cancer	0.00027	0.00197	CcSEcCtD
Allopurinol—Nervous system disorder—Cisplatin—esophageal cancer	0.00027	0.00197	CcSEcCtD
Allopurinol—Thrombocytopenia—Cisplatin—esophageal cancer	0.000269	0.00197	CcSEcCtD
Allopurinol—Skin disorder—Cisplatin—esophageal cancer	0.000267	0.00195	CcSEcCtD
Allopurinol—Eye disorder—Capecitabine—esophageal cancer	0.000267	0.00195	CcSEcCtD
Allopurinol—Tinnitus—Capecitabine—esophageal cancer	0.000266	0.00195	CcSEcCtD
Allopurinol—Hyperhidrosis—Cisplatin—esophageal cancer	0.000266	0.00194	CcSEcCtD
Allopurinol—Asthma—Methotrexate—esophageal cancer	0.000265	0.00194	CcSEcCtD
Allopurinol—Cardiac disorder—Capecitabine—esophageal cancer	0.000265	0.00194	CcSEcCtD
Allopurinol—Flushing—Capecitabine—esophageal cancer	0.000265	0.00194	CcSEcCtD
Allopurinol—Eosinophilia—Methotrexate—esophageal cancer	0.000263	0.00192	CcSEcCtD
Allopurinol—Anorexia—Cisplatin—esophageal cancer	0.000262	0.00192	CcSEcCtD
Allopurinol—Immune system disorder—Capecitabine—esophageal cancer	0.000258	0.00189	CcSEcCtD
Allopurinol—Hypotension—Cisplatin—esophageal cancer	0.000257	0.00188	CcSEcCtD
Allopurinol—Chills—Capecitabine—esophageal cancer	0.000256	0.00187	CcSEcCtD
Allopurinol—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—esophageal cancer	0.000255	0.00468	CbGpPWpGaD
Allopurinol—SLC22A7—Fluoropyrimidine Activity—TP53—esophageal cancer	0.000253	0.00464	CbGpPWpGaD
Allopurinol—Alopecia—Capecitabine—esophageal cancer	0.000252	0.00184	CcSEcCtD
Allopurinol—Pancytopenia—Methotrexate—esophageal cancer	0.000252	0.00184	CcSEcCtD
Allopurinol—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000251	0.00183	CcSEcCtD
Allopurinol—Mental disorder—Capecitabine—esophageal cancer	0.00025	0.00183	CcSEcCtD
Allopurinol—Malnutrition—Capecitabine—esophageal cancer	0.000248	0.00182	CcSEcCtD
Allopurinol—Dysuria—Methotrexate—esophageal cancer	0.000248	0.00182	CcSEcCtD
Allopurinol—Neutropenia—Methotrexate—esophageal cancer	0.000248	0.00182	CcSEcCtD
Allopurinol—Paraesthesia—Cisplatin—esophageal cancer	0.000247	0.00181	CcSEcCtD
Allopurinol—Flatulence—Capecitabine—esophageal cancer	0.000245	0.00179	CcSEcCtD
Allopurinol—Erectile dysfunction—Methotrexate—esophageal cancer	0.000244	0.00179	CcSEcCtD
Allopurinol—Dysgeusia—Capecitabine—esophageal cancer	0.000243	0.00178	CcSEcCtD
Allopurinol—Decreased appetite—Cisplatin—esophageal cancer	0.000239	0.00175	CcSEcCtD
Allopurinol—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000237	0.00174	CcSEcCtD
Allopurinol—Drowsiness—Methotrexate—esophageal cancer	0.000237	0.00173	CcSEcCtD
Allopurinol—Depression—Methotrexate—esophageal cancer	0.000236	0.00173	CcSEcCtD
Allopurinol—Pain—Cisplatin—esophageal cancer	0.000235	0.00172	CcSEcCtD
Allopurinol—XDH—Selenium Micronutrient Network—PTGS2—esophageal cancer	0.000235	0.00431	CbGpPWpGaD
Allopurinol—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000235	0.00172	CcSEcCtD
Allopurinol—Tremor—Capecitabine—esophageal cancer	0.000233	0.0017	CcSEcCtD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000231	0.00424	CbGpPWpGaD
Allopurinol—Stomatitis—Methotrexate—esophageal cancer	0.000231	0.00169	CcSEcCtD
Allopurinol—Ill-defined disorder—Capecitabine—esophageal cancer	0.00023	0.00169	CcSEcCtD
Allopurinol—Conjunctivitis—Methotrexate—esophageal cancer	0.00023	0.00168	CcSEcCtD
Allopurinol—Anaemia—Capecitabine—esophageal cancer	0.00023	0.00168	CcSEcCtD
Allopurinol—Sweating—Methotrexate—esophageal cancer	0.000227	0.00166	CcSEcCtD
Allopurinol—Feeling abnormal—Cisplatin—esophageal cancer	0.000227	0.00166	CcSEcCtD
Allopurinol—Haematuria—Methotrexate—esophageal cancer	0.000226	0.00165	CcSEcCtD
Allopurinol—Malaise—Capecitabine—esophageal cancer	0.000224	0.00164	CcSEcCtD
Allopurinol—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000224	0.00164	CcSEcCtD
Allopurinol—Epistaxis—Methotrexate—esophageal cancer	0.000223	0.00163	CcSEcCtD
Allopurinol—Vertigo—Capecitabine—esophageal cancer	0.000223	0.00163	CcSEcCtD
Allopurinol—Leukopenia—Capecitabine—esophageal cancer	0.000222	0.00163	CcSEcCtD
Allopurinol—Agranulocytosis—Methotrexate—esophageal cancer	0.000221	0.00162	CcSEcCtD
Allopurinol—Body temperature increased—Cisplatin—esophageal cancer	0.000217	0.00159	CcSEcCtD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000217	0.00398	CbGpPWpGaD
Allopurinol—Hypertension—Capecitabine—esophageal cancer	0.000214	0.00157	CcSEcCtD
Allopurinol—Haemoglobin—Methotrexate—esophageal cancer	0.000214	0.00156	CcSEcCtD
Allopurinol—Hepatitis—Methotrexate—esophageal cancer	0.000212	0.00155	CcSEcCtD
Allopurinol—Haemorrhage—Methotrexate—esophageal cancer	0.000212	0.00155	CcSEcCtD
Allopurinol—Arthralgia—Capecitabine—esophageal cancer	0.000211	0.00155	CcSEcCtD
Allopurinol—Myalgia—Capecitabine—esophageal cancer	0.000211	0.00155	CcSEcCtD
Allopurinol—Pharyngitis—Methotrexate—esophageal cancer	0.000211	0.00154	CcSEcCtD
Allopurinol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00021	0.00154	CcSEcCtD
Allopurinol—Urinary tract disorder—Methotrexate—esophageal cancer	0.00021	0.00153	CcSEcCtD
Allopurinol—Discomfort—Capecitabine—esophageal cancer	0.000209	0.00153	CcSEcCtD
Allopurinol—Urethral disorder—Methotrexate—esophageal cancer	0.000208	0.00152	CcSEcCtD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000206	0.00377	CbGpPWpGaD
Allopurinol—Visual impairment—Methotrexate—esophageal cancer	0.000205	0.0015	CcSEcCtD
Allopurinol—Confusional state—Capecitabine—esophageal cancer	0.000204	0.0015	CcSEcCtD
Allopurinol—Oedema—Capecitabine—esophageal cancer	0.000203	0.00148	CcSEcCtD
Allopurinol—Hypersensitivity—Cisplatin—esophageal cancer	0.000203	0.00148	CcSEcCtD
Allopurinol—Infection—Capecitabine—esophageal cancer	0.000201	0.00147	CcSEcCtD
Allopurinol—Erythema multiforme—Methotrexate—esophageal cancer	0.000201	0.00147	CcSEcCtD
Allopurinol—Nervous system disorder—Capecitabine—esophageal cancer	0.000199	0.00145	CcSEcCtD
Allopurinol—Eye disorder—Methotrexate—esophageal cancer	0.000199	0.00145	CcSEcCtD
Allopurinol—Thrombocytopenia—Capecitabine—esophageal cancer	0.000198	0.00145	CcSEcCtD
Allopurinol—AOX1—Disease—SLC52A3—esophageal cancer	0.000198	0.00363	CbGpPWpGaD
Allopurinol—Tinnitus—Methotrexate—esophageal cancer	0.000198	0.00145	CcSEcCtD
Allopurinol—Asthenia—Cisplatin—esophageal cancer	0.000197	0.00144	CcSEcCtD
Allopurinol—Cardiac disorder—Methotrexate—esophageal cancer	0.000197	0.00144	CcSEcCtD
Allopurinol—Skin disorder—Capecitabine—esophageal cancer	0.000197	0.00144	CcSEcCtD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000196	0.0036	CbGpPWpGaD
Allopurinol—Hyperhidrosis—Capecitabine—esophageal cancer	0.000196	0.00143	CcSEcCtD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000194	0.00356	CbGpPWpGaD
Allopurinol—Anorexia—Capecitabine—esophageal cancer	0.000193	0.00141	CcSEcCtD
Allopurinol—Immune system disorder—Methotrexate—esophageal cancer	0.000192	0.0014	CcSEcCtD
Allopurinol—Chills—Methotrexate—esophageal cancer	0.000191	0.00139	CcSEcCtD
Allopurinol—Hypotension—Capecitabine—esophageal cancer	0.000189	0.00139	CcSEcCtD
Allopurinol—AOX1—Disease—KMT2D—esophageal cancer	0.000189	0.00347	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000188	0.00345	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000188	0.00345	CbGpPWpGaD
Allopurinol—Diarrhoea—Cisplatin—esophageal cancer	0.000188	0.00138	CcSEcCtD
Allopurinol—Alopecia—Methotrexate—esophageal cancer	0.000188	0.00137	CcSEcCtD
Allopurinol—Mental disorder—Methotrexate—esophageal cancer	0.000186	0.00136	CcSEcCtD
Allopurinol—Malnutrition—Methotrexate—esophageal cancer	0.000185	0.00135	CcSEcCtD
Allopurinol—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000185	0.00135	CcSEcCtD
Allopurinol—Insomnia—Capecitabine—esophageal cancer	0.000183	0.00134	CcSEcCtD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000182	0.00335	CbGpPWpGaD
Allopurinol—Paraesthesia—Capecitabine—esophageal cancer	0.000182	0.00133	CcSEcCtD
Allopurinol—Dysgeusia—Methotrexate—esophageal cancer	0.000181	0.00132	CcSEcCtD
Allopurinol—Dyspepsia—Capecitabine—esophageal cancer	0.000178	0.00131	CcSEcCtD
Allopurinol—Decreased appetite—Capecitabine—esophageal cancer	0.000176	0.00129	CcSEcCtD
Allopurinol—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000175	0.00128	CcSEcCtD
Allopurinol—Vomiting—Cisplatin—esophageal cancer	0.000175	0.00128	CcSEcCtD
Allopurinol—Rash—Cisplatin—esophageal cancer	0.000173	0.00127	CcSEcCtD
Allopurinol—Pain—Capecitabine—esophageal cancer	0.000173	0.00127	CcSEcCtD
Allopurinol—Constipation—Capecitabine—esophageal cancer	0.000173	0.00127	CcSEcCtD
Allopurinol—Dermatitis—Cisplatin—esophageal cancer	0.000173	0.00127	CcSEcCtD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000173	0.00317	CbGpPWpGaD
Allopurinol—Ill-defined disorder—Methotrexate—esophageal cancer	0.000172	0.00125	CcSEcCtD
Allopurinol—Anaemia—Methotrexate—esophageal cancer	0.000171	0.00125	CcSEcCtD
Allopurinol—Feeling abnormal—Capecitabine—esophageal cancer	0.000167	0.00122	CcSEcCtD
Allopurinol—Malaise—Methotrexate—esophageal cancer	0.000167	0.00122	CcSEcCtD
Allopurinol—Vertigo—Methotrexate—esophageal cancer	0.000166	0.00122	CcSEcCtD
Allopurinol—AOX1—Metabolism—BLVRB—esophageal cancer	0.000166	0.00304	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—SLC52A3—esophageal cancer	0.000166	0.00304	CbGpPWpGaD
Allopurinol—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000166	0.00121	CcSEcCtD
Allopurinol—Leukopenia—Methotrexate—esophageal cancer	0.000166	0.00121	CcSEcCtD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000165	0.00303	CbGpPWpGaD
Allopurinol—Nausea—Cisplatin—esophageal cancer	0.000163	0.00119	CcSEcCtD
Allopurinol—Urticaria—Capecitabine—esophageal cancer	0.000161	0.00118	CcSEcCtD
Allopurinol—Abdominal pain—Capecitabine—esophageal cancer	0.00016	0.00117	CcSEcCtD
Allopurinol—Body temperature increased—Capecitabine—esophageal cancer	0.00016	0.00117	CcSEcCtD
Allopurinol—Convulsion—Methotrexate—esophageal cancer	0.00016	0.00117	CcSEcCtD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000158	0.0029	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000158	0.0029	CbGpPWpGaD
Allopurinol—Arthralgia—Methotrexate—esophageal cancer	0.000157	0.00115	CcSEcCtD
Allopurinol—Myalgia—Methotrexate—esophageal cancer	0.000157	0.00115	CcSEcCtD
Allopurinol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000156	0.00114	CcSEcCtD
Allopurinol—Discomfort—Methotrexate—esophageal cancer	0.000156	0.00114	CcSEcCtD
Allopurinol—XDH—Metabolism—BLVRB—esophageal cancer	0.000154	0.00283	CbGpPWpGaD
Allopurinol—XDH—Metabolism—SLC52A3—esophageal cancer	0.000154	0.00283	CbGpPWpGaD
Allopurinol—Confusional state—Methotrexate—esophageal cancer	0.000152	0.00111	CcSEcCtD
Allopurinol—Anaphylactic shock—Methotrexate—esophageal cancer	0.000151	0.0011	CcSEcCtD
Allopurinol—Infection—Methotrexate—esophageal cancer	0.00015	0.0011	CcSEcCtD
Allopurinol—Hypersensitivity—Capecitabine—esophageal cancer	0.000149	0.00109	CcSEcCtD
Allopurinol—Nervous system disorder—Methotrexate—esophageal cancer	0.000148	0.00108	CcSEcCtD
Allopurinol—Thrombocytopenia—Methotrexate—esophageal cancer	0.000148	0.00108	CcSEcCtD
Allopurinol—Skin disorder—Methotrexate—esophageal cancer	0.000147	0.00107	CcSEcCtD
Allopurinol—AOX1—Disease—FKBP1A—esophageal cancer	0.000147	0.00269	CbGpPWpGaD
Allopurinol—Hyperhidrosis—Methotrexate—esophageal cancer	0.000146	0.00107	CcSEcCtD
Allopurinol—Asthenia—Capecitabine—esophageal cancer	0.000145	0.00106	CcSEcCtD
Allopurinol—Anorexia—Methotrexate—esophageal cancer	0.000144	0.00105	CcSEcCtD
Allopurinol—Pruritus—Capecitabine—esophageal cancer	0.000143	0.00105	CcSEcCtD
Allopurinol—AOX1—Disease—DOCK2—esophageal cancer	0.000143	0.00263	CbGpPWpGaD
Allopurinol—AOX1—Disease—WIF1—esophageal cancer	0.000143	0.00263	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000143	0.00262	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—CA1—esophageal cancer	0.000141	0.00259	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—SLC10A2—esophageal cancer	0.000141	0.00259	CbGpPWpGaD
Allopurinol—Hypotension—Methotrexate—esophageal cancer	0.000141	0.00103	CcSEcCtD
Allopurinol—Diarrhoea—Capecitabine—esophageal cancer	0.000139	0.00101	CcSEcCtD
Allopurinol—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000138	0.00101	CcSEcCtD
Allopurinol—Insomnia—Methotrexate—esophageal cancer	0.000137	0.000998	CcSEcCtD
Allopurinol—Paraesthesia—Methotrexate—esophageal cancer	0.000136	0.000991	CcSEcCtD
Allopurinol—Somnolence—Methotrexate—esophageal cancer	0.000134	0.000981	CcSEcCtD
Allopurinol—Dizziness—Capecitabine—esophageal cancer	0.000134	0.000981	CcSEcCtD
Allopurinol—Dyspepsia—Methotrexate—esophageal cancer	0.000133	0.000972	CcSEcCtD
Allopurinol—AOX1—Disease—CSNK1A1—esophageal cancer	0.000132	0.00242	CbGpPWpGaD
Allopurinol—Decreased appetite—Methotrexate—esophageal cancer	0.000131	0.00096	CcSEcCtD
Allopurinol—XDH—Metabolism—SLC10A2—esophageal cancer	0.000131	0.00241	CbGpPWpGaD
Allopurinol—XDH—Metabolism—CA1—esophageal cancer	0.000131	0.00241	CbGpPWpGaD
Allopurinol—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00013	0.000953	CcSEcCtD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000129	0.00237	CbGpPWpGaD
Allopurinol—Pain—Methotrexate—esophageal cancer	0.000129	0.000944	CcSEcCtD
Allopurinol—AOX1—Metabolism—CA2—esophageal cancer	0.000129	0.00237	CbGpPWpGaD
Allopurinol—Vomiting—Capecitabine—esophageal cancer	0.000129	0.000943	CcSEcCtD
Allopurinol—Rash—Capecitabine—esophageal cancer	0.000128	0.000935	CcSEcCtD
Allopurinol—Dermatitis—Capecitabine—esophageal cancer	0.000128	0.000934	CcSEcCtD
Allopurinol—Headache—Capecitabine—esophageal cancer	0.000127	0.000929	CcSEcCtD
Allopurinol—Feeling abnormal—Methotrexate—esophageal cancer	0.000124	0.00091	CcSEcCtD
Allopurinol—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000123	0.000903	CcSEcCtD
Allopurinol—Nausea—Capecitabine—esophageal cancer	0.00012	0.000881	CcSEcCtD
Allopurinol—AOX1—Metabolism—PLCE1—esophageal cancer	0.00012	0.0022	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—ADH7—esophageal cancer	0.00012	0.0022	CbGpPWpGaD
Allopurinol—XDH—Metabolism—CA2—esophageal cancer	0.00012	0.0022	CbGpPWpGaD
Allopurinol—Urticaria—Methotrexate—esophageal cancer	0.00012	0.000877	CcSEcCtD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.00012	0.0022	CbGpPWpGaD
Allopurinol—Body temperature increased—Methotrexate—esophageal cancer	0.000119	0.000873	CcSEcCtD
Allopurinol—Abdominal pain—Methotrexate—esophageal cancer	0.000119	0.000873	CcSEcCtD
Allopurinol—XDH—Metabolism—PLCE1—esophageal cancer	0.000111	0.00205	CbGpPWpGaD
Allopurinol—XDH—Metabolism—ADH7—esophageal cancer	0.000111	0.00205	CbGpPWpGaD
Allopurinol—Hypersensitivity—Methotrexate—esophageal cancer	0.000111	0.000813	CcSEcCtD
Allopurinol—AOX1—Disease—ELMO1—esophageal cancer	0.000111	0.00204	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000109	0.002	CbGpPWpGaD
Allopurinol—AOX1—Disease—TPI1—esophageal cancer	0.000109	0.00199	CbGpPWpGaD
Allopurinol—AOX1—Disease—GSTO1—esophageal cancer	0.000109	0.00199	CbGpPWpGaD
Allopurinol—Asthenia—Methotrexate—esophageal cancer	0.000108	0.000792	CcSEcCtD
Allopurinol—Pruritus—Methotrexate—esophageal cancer	0.000107	0.000781	CcSEcCtD
Allopurinol—AOX1—Metabolism—ADH1B—esophageal cancer	0.000105	0.00193	CbGpPWpGaD
Allopurinol—AOX1—Disease—ALDOB—esophageal cancer	0.000104	0.00191	CbGpPWpGaD
Allopurinol—Diarrhoea—Methotrexate—esophageal cancer	0.000103	0.000755	CcSEcCtD
Allopurinol—AOX1—Metabolism—TYMP—esophageal cancer	0.000101	0.00184	CbGpPWpGaD
Allopurinol—AOX1—Disease—HIST1H2BM—esophageal cancer	0.0001	0.00184	CbGpPWpGaD
Allopurinol—AOX1—Disease—GAPDH—esophageal cancer	0.0001	0.00184	CbGpPWpGaD
Allopurinol—Dizziness—Methotrexate—esophageal cancer	9.98e-05	0.00073	CcSEcCtD
Allopurinol—AOX1—Metabolism—CYP26A1—esophageal cancer	9.78e-05	0.00179	CbGpPWpGaD
Allopurinol—XDH—Metabolism—ADH1B—esophageal cancer	9.78e-05	0.00179	CbGpPWpGaD
Allopurinol—Vomiting—Methotrexate—esophageal cancer	9.6e-05	0.000702	CcSEcCtD
Allopurinol—AOX1—Metabolism—ALOX15—esophageal cancer	9.53e-05	0.00175	CbGpPWpGaD
Allopurinol—Rash—Methotrexate—esophageal cancer	9.52e-05	0.000696	CcSEcCtD
Allopurinol—Dermatitis—Methotrexate—esophageal cancer	9.51e-05	0.000695	CcSEcCtD
Allopurinol—Headache—Methotrexate—esophageal cancer	9.45e-05	0.000692	CcSEcCtD
Allopurinol—XDH—Metabolism—TYMP—esophageal cancer	9.34e-05	0.00171	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—GSTO1—esophageal cancer	9.09e-05	0.00167	CbGpPWpGaD
Allopurinol—XDH—Metabolism—CYP26A1—esophageal cancer	9.09e-05	0.00167	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—TPI1—esophageal cancer	9.09e-05	0.00167	CbGpPWpGaD
Allopurinol—Nausea—Methotrexate—esophageal cancer	8.96e-05	0.000656	CcSEcCtD
Allopurinol—XDH—Metabolism—ALOX15—esophageal cancer	8.86e-05	0.00162	CbGpPWpGaD
Allopurinol—AOX1—Disease—XIAP—esophageal cancer	8.85e-05	0.00162	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—ALDOB—esophageal cancer	8.71e-05	0.0016	CbGpPWpGaD
Allopurinol—XDH—Metabolism—TPI1—esophageal cancer	8.45e-05	0.00155	CbGpPWpGaD
Allopurinol—XDH—Metabolism—GSTO1—esophageal cancer	8.45e-05	0.00155	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—GAPDH—esophageal cancer	8.39e-05	0.00154	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—CRABP1—esophageal cancer	8.31e-05	0.00152	CbGpPWpGaD
Allopurinol—AOX1—Disease—B2M—esophageal cancer	8.22e-05	0.00151	CbGpPWpGaD
Allopurinol—XDH—Metabolism—ALDOB—esophageal cancer	8.1e-05	0.00149	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—GNG7—esophageal cancer	7.91e-05	0.00145	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—HMOX1—esophageal cancer	7.89e-05	0.00145	CbGpPWpGaD
Allopurinol—AOX1—Disease—ENO1—esophageal cancer	7.89e-05	0.00145	CbGpPWpGaD
Allopurinol—XDH—Metabolism—GAPDH—esophageal cancer	7.8e-05	0.00143	CbGpPWpGaD
Allopurinol—AOX1—Disease—PSME1—esophageal cancer	7.77e-05	0.00143	CbGpPWpGaD
Allopurinol—AOX1—Disease—PSME2—esophageal cancer	7.77e-05	0.00143	CbGpPWpGaD
Allopurinol—XDH—Metabolism—CRABP1—esophageal cancer	7.73e-05	0.00142	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—ABCB1—esophageal cancer	7.57e-05	0.00139	CbGpPWpGaD
Allopurinol—AOX1—Disease—CALR—esophageal cancer	7.46e-05	0.00137	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—ALDH2—esophageal cancer	7.41e-05	0.00136	CbGpPWpGaD
Allopurinol—XDH—Metabolism—GNG7—esophageal cancer	7.35e-05	0.00135	CbGpPWpGaD
Allopurinol—AOX1—Disease—FBXW7—esophageal cancer	7.21e-05	0.00132	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—GSTT1—esophageal cancer	7.05e-05	0.00129	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—CYP2A6—esophageal cancer	6.97e-05	0.00128	CbGpPWpGaD
Allopurinol—XDH—Metabolism—ALDH2—esophageal cancer	6.89e-05	0.00126	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—HMOX1—esophageal cancer	6.63e-05	0.00122	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—PTGS1—esophageal cancer	6.6e-05	0.00121	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—ENO1—esophageal cancer	6.6e-05	0.00121	CbGpPWpGaD
Allopurinol—XDH—Metabolism—GSTT1—esophageal cancer	6.55e-05	0.0012	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—PSME2—esophageal cancer	6.51e-05	0.00119	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—PSME1—esophageal cancer	6.51e-05	0.00119	CbGpPWpGaD
Allopurinol—XDH—Metabolism—CYP2A6—esophageal cancer	6.48e-05	0.00119	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—ABCB1—esophageal cancer	6.36e-05	0.00117	CbGpPWpGaD
Allopurinol—XDH—Metabolism—ENO1—esophageal cancer	6.14e-05	0.00113	CbGpPWpGaD
Allopurinol—XDH—Metabolism—PTGS1—esophageal cancer	6.14e-05	0.00113	CbGpPWpGaD
Allopurinol—XDH—Metabolism—PSME2—esophageal cancer	6.05e-05	0.00111	CbGpPWpGaD
Allopurinol—XDH—Metabolism—PSME1—esophageal cancer	6.05e-05	0.00111	CbGpPWpGaD
Allopurinol—AOX1—Disease—TGFBR2—esophageal cancer	5.83e-05	0.00107	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—CYP1B1—esophageal cancer	5.62e-05	0.00103	CbGpPWpGaD
Allopurinol—AOX1—Disease—SMAD4—esophageal cancer	5.52e-05	0.00101	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—CYP19A1—esophageal cancer	5.28e-05	0.000968	CbGpPWpGaD
Allopurinol—XDH—Metabolism—CYP1B1—esophageal cancer	5.22e-05	0.000958	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.06e-05	0.000928	CbGpPWpGaD
Allopurinol—XDH—Metabolism—CYP19A1—esophageal cancer	4.91e-05	0.0009	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—HMOX1—esophageal cancer	4.82e-05	0.000884	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—ABCB1—esophageal cancer	4.62e-05	0.000848	CbGpPWpGaD
Allopurinol—AOX1—Disease—HIF1A—esophageal cancer	4.52e-05	0.000829	CbGpPWpGaD
Allopurinol—XDH—Metabolism—HMOX1—esophageal cancer	4.48e-05	0.000822	CbGpPWpGaD
Allopurinol—XDH—Metabolism—ABCB1—esophageal cancer	4.3e-05	0.000789	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.25e-05	0.00078	CbGpPWpGaD
Allopurinol—AOX1—Disease—NOS2—esophageal cancer	4.11e-05	0.000754	CbGpPWpGaD
Allopurinol—AOX1—Disease—NOTCH1—esophageal cancer	4.07e-05	0.000747	CbGpPWpGaD
Allopurinol—AOX1—Disease—CREBBP—esophageal cancer	3.69e-05	0.000677	CbGpPWpGaD
Allopurinol—AOX1—Disease—NOS3—esophageal cancer	3.3e-05	0.000606	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—CREBBP—esophageal cancer	3.09e-05	0.000567	CbGpPWpGaD
Allopurinol—AOX1—Disease—ERBB2—esophageal cancer	3.09e-05	0.000567	CbGpPWpGaD
Allopurinol—AOX1—Disease—PTGS2—esophageal cancer	3.02e-05	0.000554	CbGpPWpGaD
Allopurinol—XDH—Metabolism—CREBBP—esophageal cancer	2.87e-05	0.000527	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—NOS3—esophageal cancer	2.77e-05	0.000508	CbGpPWpGaD
Allopurinol—AOX1—Disease—CDKN1A—esophageal cancer	2.64e-05	0.000485	CbGpPWpGaD
Allopurinol—XDH—Metabolism—NOS3—esophageal cancer	2.57e-05	0.000472	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—PTGS2—esophageal cancer	2.53e-05	0.000464	CbGpPWpGaD
Allopurinol—AOX1—Disease—EP300—esophageal cancer	2.51e-05	0.000461	CbGpPWpGaD
Allopurinol—XDH—Metabolism—PTGS2—esophageal cancer	2.35e-05	0.000432	CbGpPWpGaD
Allopurinol—AOX1—Disease—MYC—esophageal cancer	2.19e-05	0.000402	CbGpPWpGaD
Allopurinol—AOX1—Disease—EGFR—esophageal cancer	2.14e-05	0.000393	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—EP300—esophageal cancer	2.1e-05	0.000386	CbGpPWpGaD
Allopurinol—XDH—Metabolism—EP300—esophageal cancer	1.96e-05	0.000359	CbGpPWpGaD
Allopurinol—AOX1—Disease—PIK3CA—esophageal cancer	1.86e-05	0.000341	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—PIK3CA—esophageal cancer	1.56e-05	0.000286	CbGpPWpGaD
Allopurinol—XDH—Metabolism—PIK3CA—esophageal cancer	1.45e-05	0.000266	CbGpPWpGaD
